These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20171408)

  • 41. Failure of prolonged dilation to improve long-term patency of femoropopliteal artery angioplasty: results of a prospective trial.
    Söder HK; Manninen HI; Räsänen HT; Kaukanen E; Jaakkola P; Matsi PJ
    J Vasc Interv Radiol; 2002 Apr; 13(4):361-9. PubMed ID: 11932366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
    Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
    Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries.
    Karch LA; Mattos MA; Henretta JP; McLafferty RB; Ramsey DE; Hodgson KJ
    J Vasc Surg; 2000 May; 31(5):880-7. PubMed ID: 10805877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    Krishnan P; Farhan S; Schneider P; Kamran H; Iida O; Brodmann M; Micari A; Sachar R; Urasawa K; Scheinert D; Ando K; Tarricone A; Doros G; Tepe G; Yokoi H; Laird J; Zeller T
    J Am Coll Cardiol; 2022 Sep; 80(13):1241-1250. PubMed ID: 36137674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial.
    Spiliopoulos S; Katsanos K; Karnabatidis D; Diamantopoulos A; Kagadis GC; Christeas N; Siablis D
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):929-38. PubMed ID: 20574796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
    Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV
    J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smaller Superficial Femoral Artery is Associated with Worse Outcomes after Percutaneous Transluminal Angioplasty for De Novo Atherosclerotic Disease.
    Chang H; Veith FJ; Rockman CB; Cayne NS; Babaev A; Jacobowitz GR; Ramkhelawon B; Patel VI; Garg K
    Ann Vasc Surg; 2021 Oct; 76():38-48. PubMed ID: 33838233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictor analysis of 1-year restenosis after percutaneous transluminal angioplasty for femoropopliteal stenotic lesions using intravascular ultrasound.
    Kakizaki S; Kozuki A; Kijima Y; Nagoshi R; Fujiwara R; Shibata H; Suzuki A; Fujimoto D; Kyo S; Masuko E; Miyata T; Shite J
    Heart Vessels; 2021 Nov; 36(11):1661-1669. PubMed ID: 33830317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease.
    Siracuse JJ; Giles KA; Pomposelli FB; Hamdan AD; Wyers MC; Chaikof EL; Nedeau AE; Schermerhorn ML
    J Vasc Surg; 2012 Apr; 55(4):1001-7. PubMed ID: 22301210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.
    Zlatanovic P; Mahmoud AA; Cinara I; Cvetic V; Lukic B; Davidovic L
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):258-269. PubMed ID: 33334672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angioplasty versus bare metal stenting for superficial femoral artery lesions.
    Chowdhury MM; McLain AD; Twine CP
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.
    Laird JR; Schneider PA; Tepe G; Brodmann M; Zeller T; Metzger C; Krishnan P; Scheinert D; Micari A; Cohen DJ; Wang H; Hasenbank MS; Jaff MR;
    J Am Coll Cardiol; 2015 Dec; 66(21):2329-2338. PubMed ID: 26476467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty.
    Soga Y; Iida O; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H
    J Endovasc Ther; 2020 Dec; 27(6):946-955. PubMed ID: 32865145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
    Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
    J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.